DEVELOPMENT OF ABATACEPT- AND ADALIMUMAB-SPECIFIC PREDICTIVE MODELS OF RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS USING DATA FROM A HEAD-TO-HEAD STUDY

被引：0

作者：

Bandyopadhyay, Somnath ^{[1
]}

Maldonado, Michael A. ^{[2
]}

Ammar, Ron ^{[1
]}

Schiff, Michael ^{[3
]}

Weinblatt, Michael ^{[4
]}

Fleischmann, Roy ^{[5
]}

Connolly, Sean E. ^{[6
]}

机构：

[1] Bristol Myers Squibb, Translat Bioinformat, Princeton, NJ USA

[2] Bristol Myers Squibb, Immunosci R&D, Princeton, NJ USA

[3] Univ Colorado, Div Rheumatol, Denver, CO 80202 USA

[4] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA

[5] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA

[6] Bristol Myers Squibb, Marketed Prod Dev, Princeton, NJ USA

来源：

RHEUMATOLOGY | 2018年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

221

引用

页数：1

共 50 条

[1] Development of Abatacept- and Adalimumab-Specific Predictive Models of Response to Therapy in RA Using Data from a Head-to-Head Study
Bandyopadhyay, S.
Maldonado, M. A.
Ammar, R.
Schiff, Michael
Weinblatt, Michael
Fleischmann, Roy
Connolly, S. E.
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[2] Head-to-head trial shows abatacept is as effective as adalimumab in patients with active rheumatoid arthritis
Mayor, Susan
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (08) : 431 - 431
[3] COST-EFFECTIVENESS OF ABATACEPT COMPARED TO ADALIMUMAB IN ITALY BASED ON A HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS
Gaultney, J.
Nappi, C.
Benucci, M.
Iannazzo, S.
Sion, K.
Alemao, E.
Sabater, J.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A644 - A644
[4] COST COMPARISON OF ABATACEPT AND ADALIMUMAB BASED ON AMPLE, A 2-YEAR HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS
Gaultney, J.
Budd, D.
Nappi, C.
Benucci, M.
Iannazzo, S.
Alemao, E.
Sabater, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 551 - 552
[5] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
Weinblatt, Michael E.
Schiff, Michael
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
Maldonado, Michael
Fleischmann, Roy
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 28 - 38
[6] Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
Fleischmann, Roy
Weinblatt, Michael E.
Schiff, Michael
Khanna, Dinesh
Maldonado, Michael A.
Nadkarni, Anagha
Furst, Daniel E.
[J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (07) : 907 - 913
[7] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VS ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: KEY EFFICACY AND SAFETY RESULTS FROM THE AMPLE TRIAL
Weinblatt, Michael E.
Schiff, Michael H.
Fleischmann, Roy
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
Maldonado, Michael A.
[J]. RHEUMATOLOGY, 2013, 52 : 45 - 46
[8] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
Weinblatt, Michael E.
Schiff, Michael H.
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael A.
Fleischmann, Roy
[J]. RHEUMATOLOGY, 2014, 53 : 88 - 88
[9] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Schiff, Michael
Weinblatt, Michael E.
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Elegbe, Ayanbola
Maldonado, Michael
Fleischmann, Roy
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 86 - 94
[10] Impact of Glucocorticoid Therapy on the Efficacy of SC Abatacept or Adalimumab in RA Patients with Inadequate Response to MTX: A Post Hoc Analysis of Data from a Head-to-Head Trial
Degboe, Yannick
Schiff, Michael
Weinblatt, Michael
Fleischmann, Roy
Ahmad, H. A.
Constantin, Arnaud
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69

← 1 2 3 4 5 →